Amalia Gomez-Bernal
Overview
    Explore the profile of Amalia Gomez-Bernal including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              5
            
            
              Citations
              27
            
            
              Followers
              0
            
  
  Related Specialty
          Related Specialty
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Martinez-Janez N, Chacon I, de Juan A, Cruz-Merino L, Del Barco S, Fernandez I, et al.
  
  
    Breast Care (Basel)
    . 2016 May;
          11(2):133-8.
    
    PMID: 27239176
  
  
          Background: The aim of this project was to provide an expert opinion regarding anti-human epidermal growth factor receptor 2 (HER2) therapy beyond second-line treatment of metastatic breast cancer (mBC). Methods:...
      
2.
        
    
    Bayo-Calero J, Mayordomo J, Sanchez-Rovira P, Perez-Carrion R, Illaramendi J, Garcia-Bueno J, et al.
  
  
    Clin Breast Cancer
    . 2008 Jul;
          8(3):264-8.
    
    PMID: 18650157
  
  
          Background: Trastuzumab combined with cytotoxic agents presents encouraging results in metastatic breast cancer (MBC), but cardiac toxicity limits some combinations. The synergism shown with trastuzumab and the favorable tolerability profile...
      
3.
        
    
    Salazar R, Cruz-Hernandez J, Sanchez-Valdivieso E, Rodriguez C, Gomez-Bernal A, Barco E, et al.
  
  
    Cancer Lett
    . 2005 May;
          233(1):172-7.
    
    PMID: 15876480
  
  
          We carried out a mutational analysis of BRCA1 and BRCA2 genes in 103 individuals from a population in Western Central Spain and we identified nine new variants: two truncating mutations...
      
4.
        
    
    Gomez-Bernal A, Cruz J, Olaverri A, Arizcun A, Martin T, Rodriguez C, et al.
  
  
    Anticancer Drugs
    . 2004 Dec;
          16(1):77-82.
    
    PMID: 15613908
  
  
          This phase II trial evaluated the efficacy and toxicity of vinorelbine 25 mg/m2 plus docetaxel 60 mg2/m administered on day 1, every 2 weeks with granulocyte colony-stimulating factor support (G-CSF,...
      
5.
        
    
    Gomez-Bernal A, Cruz J, Garcia-Palomo A, Arizcun A, Pujol E, Diz P, et al.
  
  
    Am J Clin Oncol
    . 2003 Apr;
          26(2):127-31.
    
    PMID: 12714881
  
  
          The aim of this study was to determine the efficacy and toxicity of a biweekly combination of docetaxel and vinorelbine in patients with metastatic breast cancer (MBC) previously treated with...